---
title: "Dr Emma Louise Cheetham — Ownership Dossier"
canonical: https://whiteintel.dev/entity/40e6c845-e39a-5ae3-a2c4-71fd495d1c1d
json: https://whiteintel.dev/api/public/dossier/40e6c845-e39a-5ae3-a2c4-71fd495d1c1d
identifier: oo-person:GB-COH-PER-NI714578-FrGLTUPpcwchcA-S8erAHvMuMo0
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Dr Emma Louise Cheetham

**Type:** Person  
**Jurisdiction:** GB  
**Identifier:** `oo-person:GB-COH-PER-NI714578-FrGLTUPpcwchcA-S8erAHvMuMo0`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/40e6c845-e39a-5ae3-a2c4-71fd495d1c1d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/40e6c845-e39a-5ae3-a2c4-71fd495d1c1d  

## Ownership & control

### Holdings / subsidiaries

- **SONAS PHARMACEUTICALS (N.I.) LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/5444c75d-fc93-5bc8-a57e-6160e6a35f1b

## Provenance

- OpenOwnership — https://www.openownership.org

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Dr Emma Louise Cheetham**. Human view: https://whiteintel.dev/entity/40e6c845-e39a-5ae3-a2c4-71fd495d1c1d · Structured JSON: https://whiteintel.dev/api/public/dossier/40e6c845-e39a-5ae3-a2c4-71fd495d1c1d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._